Factor | Wagner2008 (10130)

10.1128/aem.01132-07

Continuous CTC Use

Swine | Grower-finisher

16

Description

Chlortetracycline was fed at 100 g/ton continuously throughout the finishing period, until 2 weeks prior to marketing.

Resistance Outcomes

Resistance Microbe Outcome
Tetracycline
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous CTC Use 98.40 126
No Use 94.80 128
Ceftiofur
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous CTC Use 0.80 126
No Use 0.80 128
Amoxicillin And Beta-Lactamase Inhibitor
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous CTC Use 0.00 126
No Use 0.00 128
Ampicillin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous CTC Use 35.70 126
No Use 27.30 128
Cefalotin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous CTC Use 6.40 126
No Use 3.90 128
Cefoxitin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous CTC Use 0.00 126
No Use 0.00 128
Amikacin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous CTC Use 0.00 126
No Use 0.00 128
Ceftriaxone
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous CTC Use 0.00 126
No Use 0.00 128
Ciprofloxacin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous CTC Use 0.00 126
No Use 0.00 128
Nalidixic Acid
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous CTC Use 0.00 126
No Use 0.00 128
Chloramphenicol
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous CTC Use 8.70 126
No Use 10.20 128
Gentamicin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous CTC Use 9.50 126
No Use 6.20 128
Kanamycin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous CTC Use 23.80 126
No Use 20.30 128
Streptomycin
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous CTC Use 34.90 126
No Use 17.20 128
Sulfamethoxazole
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous CTC Use 28.60 126
No Use 18.80 128
Sulfamethoxazole And Trimethoprim
/
Escherichia coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Continuous CTC Use 1.60 126
No Use 0.80 128